How much saffron do the trials use?

30 mg per day of a standardised extract, usually split as 15 mg twice daily.

Can I use cooking saffron instead?

Not reliably. Threads vary widely in crocin content and are not dose-controlled the way trial extracts are.

How long before I notice anything?

Trials ran six to eight weeks, and that is a reasonable window before judging it.

Is it as good as an antidepressant?

The linked meta-analysis found comparable severity reductions, but the trials were small and short.

Can I take it alongside my antidepressant?

Only with your prescriber's agreement, because both act on serotonin.

Outcome

Moderate Evidence

Saffron for Pleasure Response Restoration

Saffron is the supplement with the most credible antidepressant data, and mood improvement includes anhedonia items.

Overview

Anhedonia, the loss of pleasure in things that used to be rewarding, is one of the most treatment-resistant features of low mood. It also happens to be one of the symptoms saffron trials have measured directly rather than as a footnote to a total depression score.

Saffron is unusual among botanicals in having repeated randomised comparisons against prescription antidepressants, not just placebo. The trials are small and mostly Iranian, which is the main structural weakness in the evidence base.

Verdict

Likely effective

A meta-analysis found saffron significantly better than placebo and comparable to standard antidepressants on depression severity, including anhedonia items. Small, geographically concentrated trials limit confidence.

How It Works

Saffron's principal constituents, crocin and safranal, inhibit reuptake of serotonin, dopamine and noradrenaline in preclinical models. Dopaminergic activity is the mechanistically relevant part for anhedonia specifically, since reward anticipation is a dopamine-dependent process.

Crocin is also a strong antioxidant and reduces inflammatory signalling in animal models, which connects to the inflammatory hypothesis of depression. That link is plausible and unproven in humans, and should be read as background rather than as evidence for this outcome.

Dosing & Protocol

Almost every positive trial used 30 mg per day of a standardised stigma or petal extract, usually split into two doses. This is one of the tighter dose-response pictures in botanical research: below 20 mg the signal thins, and above 30 mg there is no evidence of extra benefit.

Scenario	Dose	Form	Timing
Trial-standard dose	30 mg daily	Standardised stigma extract	15 mg twice daily
Single-dose alternative	30 mg daily	Standardised extract	Once daily with food
Lower trial dose	20 mg daily	Standardised extract	Divided
Maximum studied	30 mg daily	Any standardised extract	Do not exceed without supervision

1
Choose a standardised extract· Before starting
Culinary saffron threads are not dose-controlled. Trials used extracts standardised for crocin and safranal content.
2
Take 15 mg twice daily· Weeks 1 to 6
This mirrors the dosing used across the trials in the linked meta-analysis.
3
Allow six to eight weeks· Weeks 1 to 8
Trial durations were typically six to eight weeks, which is also the window in which antidepressant effects are conventionally judged.
4
Track reward, not just mood· Weekly
Ask specifically whether things you used to enjoy feel rewarding again; that is the anhedonia signal, and it can move separately from general mood.
5
Do not exceed 30 mg daily· Throughout
Higher doses carry toxicity concerns and no demonstrated additional benefit.

Evidence

One study is linked to this pairing: a 2013 systematic review and meta-analysis in the Journal of Integrative Medicine covering saffron for major depressive disorder and anhedonia. Saffron significantly outperformed placebo and matched standard antidepressants on depression severity, including anhedonia items.

Best linked evidence: Systematic review and meta-analysis of randomised trials
Linked result: Superior to placebo; comparable to standard antidepressants
Studied dose: 30 mg daily of standardised extract
Main limitation: Small trials concentrated in one country; short durations
Certainty: Moderate for mild to moderate depression; lower for anhedonia as an isolated endpoint

Studies linked to this pairing.

Saffron for major depressive disorder and anhedonia: a systematic review and meta-analysis

Score: 7/10

2013

meta_analysis

Hausenblas HA, Saha D, Dubyak PJ +1 more

Saffron significantly outperformed placebo and matched standard antidepressants on depression severity

View source

Safety

At 30 mg daily saffron is well tolerated, with dry mouth, mild nausea and appetite change the usual reports. Safety concerns attach to doses far above the supplemental range, which is why the ceiling matters.

Reported effects

Dry mouth

Nausea

Appetite change

Headache

Toxicity at gram-level doses

Avoid in pregnancy

High-dose saffron has uterine stimulant activity and has been associated with miscarriage. Supplemental doses are not established as safe in pregnancy and should be avoided.

Interactions & Conflicts

Because saffron acts on monoamine reuptake, the interaction that matters most is with other serotonergic agents. Combining it with prescribed antidepressants without oversight is not a benign experiment.

Interacts with	Severity	Mechanism	Action
SSRIs and SNRIs	moderate	Additive serotonergic activity	Only with prescriber oversight
MAO inhibitors	high	Risk of serotonin excess	Avoid
Anticoagulants and antiplatelets	moderate	Saffron has mild antiplatelet activity	Discuss before use
Antihypertensives	low	Possible additive blood pressure lowering	Monitor early on
Sedatives	low	Reported additive sedation in animal models	Note any added drowsiness

References

The clinical claims here rest on the linked meta-analysis. Mechanistic statements about crocin and safranal come from preclinical pharmacology and are presented as explanation, not as human outcome data.

Hausenblas HA et al. Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials. J Integr Med. 2013

Frequently Asked Questions

Medical Disclaimer

The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.